Aldesleukin (Interleukin-2)
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Aldesleukin (Interleukin-2), covering 2010-10-05 to 2025-02-06. Get the full timeline:
Most recent: Clinical Trial Update: High Dose IL-2 in Combination With Anti-PD-1 to Overcome Anti-PD-1 Resistance in Metastatic Melanoma and Renal Cell Carcinoma [Phase 2]